A detailed history of Adar1 Capital Management, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 376,737 shares of ITOS stock, worth $2.81 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
376,737
Previous 60,000 527.9%
Holding current value
$2.81 Million
Previous $890 Million 332.0%
% of portfolio
0.63%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.09 - $17.97 $3.2 Million - $5.69 Million
316,737 Added 527.9%
376,737 $3.85 Billion
Q2 2024

Aug 13, 2024

BUY
$10.33 - $18.09 $619,800 - $1.09 Million
60,000 New
60,000 $890 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $266M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.